title: A mathematical approach to estimate the efficacy of individual-donation and minipool nucleic acid amplification test options in preventing transmission risk by window period and occult hepatitis B virus infections.
abstract: BACKGROUND
  Sensitivity data from a head-to-head comparison study in South Africa were used to compare the efficacy of the Ultrio Plus assay in individual-donation (ID) and minipool (MP)4 and MP8 formats with that of TaqScreen MP6 in preventing hepatitis B virus (HBV) transmission risk.
  
  
  METHODS
  The replicate nucleic acid test (NAT) results on 106 HBV NAT (Ultrio)-yield samples and 29 HBV DNA (Ultrio)-negative, hepatitis B surface antigen (HBsAg)-positive samples were used to determine the viral load in copies/mL against the Eurohep HBV standard by probit analysis. Random viral load distributions were established in 32 pre-HBsAg window period (WP), 15 post-HBsAg WP, and 56 occult HBV infection (OBI) donations. Regression analysis of log viral load and Poisson distribution statistics of infectious HBV particles in blood components was used to predict infectivity and efficacy of NAT options in removing HBV transmission risk.
  
  
  RESULTS
  For red blood cell transfusions (20 mL of plasma), the modeling predicted an Ultrio Plus ID-NAT efficacy of 68 and 83% in removing WP and (antibody to hepatitis B surface antigen-negative) OBI transmission risk, respectively, compared to 52 and 49% by TaqScreen MP6. For 200 mL of fresh-frozen plasma the estimated efficacy levels by these ID- and MP6-NAT options reduced to 57 and 44% for WP and to 67 and 34% for OBI donations, respectively.
  
  
  CONCLUSIONS
  The efficacy of the currently available commercial NAT systems in reducing HBV transmission risk is mainly driven by the pool size and the transfusion plasma volume. The modeled OBI transmission risk and NAT efficacy levels were in line with those recently reported in three lookback studies and give more insight in the incremental safety provided by HBsAg and antibody to hepatitis B core antigen testing of ID-NAT screened blood.
authors.affiliation: South African National Blood Service (SANBS), Johannesburg, South Africa.
authors.forename: Marion
authors.initials: M
authors.lastname: Vermeulen
authors.forename: Harry
authors.initials: H
authors.lastname: van Drimmelen
authors.forename: Charl
authors.initials: C
authors.lastname: Coleman
authors.forename: Josephine
authors.initials: J
authors.lastname: Mitchel
authors.forename: Ravi
authors.initials: R
authors.lastname: Reddy
authors.forename: Nico
authors.initials: N
authors.lastname: Lelie
mesh_terms: D001782:Blood Donors; D001800:Blood Specimen Collection / Q000379:methods* / Q000706:statistics & numerical data; D004279:DNA, Viral / Q000097:blood / Q000235:genetics; D006509:Hepatitis B / Q000097:blood / Q000517:prevention & control* / Q000635:transmission; D006515:Hepatitis B virus / Q000235:genetics* / Q000276:immunology; D006801:Humans; D008962:Models, Theoretical; D021141:Nucleic Acid Amplification Techniques / Q000379:methods*; D012307:Risk Factors; D012698:Serologic Tests / Q000379:methods; D013019:South Africa; D013997:Time Factors; D019562:Viral Load
chemical_list: D004279:DNA, Viral
references.citation: J Med Virol. 2008 Dec;80(12):2064-8
references.pmid: 19040280
references.citation: Transfusion. 2008 Feb;48(2):286-94
references.pmid: 18028278
references.citation: Transfusion. 2013 Jul;53(7):1393-404
references.pmid: 23033944
references.citation: Transfusion. 2013 Jul;53(7):1405-15
references.pmid: 23362802
references.citation: Transfusion. 2013 Oct;53(10 Pt 2):2477-88
references.pmid: 23521050
references.citation: Transfusion. 2013 Oct;53(10 Pt 2):2384-98
references.pmid: 23445273
references.citation: Transfusion. 2005 Feb;45(2):254-64
references.pmid: 15660836
references.citation: Transfusion. 2012 Apr;52(4):880-92
references.pmid: 21981386
references.citation: Transfusion. 2009 Nov;49(11):2454-89
references.pmid: 19682345
references.citation: Transfusion. 2013 Oct;53(10 Pt 2):2512-24
references.pmid: 23590145
references.citation: J Clin Microbiol. 1999 Jan;37(1):68-73
references.pmid: 9854066
references.citation: Transfusion. 2007 Jul;47(7):1197-205
references.pmid: 17581154
references.citation: Transfusion. 2011 Jan;51(1):203-15
references.pmid: 20707858
references.citation: Vox Sang. 2013 Nov;105(4):290-8
references.pmid: 23802710
references.citation: Transfusion. 2013 Oct;53(10 Pt 2):2459-66
references.pmid: 23621791
references.citation: Transfusion. 1995 Jan;35(1):5-12
references.pmid: 7998069